Country - Netherlands
Summary - Custom-Made Gmp Peptides
Deadline - Feb 20, 2026
MT reference number - 103697903
Product classification - Pharmaceutical products
Address - Netherlands
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 103697903
Document Type - Tender Notices
Description - Description: The Department of Medical BioSciences from Radboudumc has been award a KWF grant for the PROTECT-lynch study. The main goal of the PROTECT-lynch study is a new treatment option for LS patients significantly improving the quality of life of LS patients and most likely the prognosis (occurrence of Lynch-related cancer(s).Standard care for healthy LS patients currently consists of undergoing intensive surveillance programs that do not guarantee timely detection of one or more Lynch-related cancers at a treatable stage. The PROTECT-lynch study may change this with its preventive dendritic cell therapy. To prepare the intended dendritic cell (DC) product for the PROTECT-lynch study,
Mt Ref Id - 103697903
Deadline - Feb 20, 2026
Similar Tenders :